Cabaletta Ebit from 2010 to 2026
| CABA Stock | USD 2.60 0.16 6.56% |
EBIT | First Reported 2018-09-30 | Previous Quarter -44.6 M | Current Value -44.3 M | Quarterly Volatility 11.6 M |
Check Cabaletta Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cabaletta Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.8 M, Interest Expense of 433.5 K or Selling General Administrative of 33.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.14 or PTB Ratio of 0.7. Cabaletta financial statements analysis is a perfect complement when working with Cabaletta Bio Valuation or Volatility modules.
Cabaletta | Ebit | Build AI portfolio with Cabaletta Stock |
Analyzing Cabaletta Bio's Ebit over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Ebit has evolved provides context for assessing Cabaletta Bio's current valuation and future prospects.
Latest Cabaletta Bio's Ebit Growth Pattern
Below is the plot of the Ebit of Cabaletta Bio over the last few years. It is Cabaletta Bio's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cabaletta Bio's overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
Cabaletta Ebit Regression Statistics
| Arithmetic Mean | (32,116,505) | |
| Coefficient Of Variation | (128.68) | |
| Mean Deviation | 34,622,241 | |
| Median | (6,193,000) | |
| Standard Deviation | 41,326,676 | |
| Sample Variance | 1707.9T | |
| Range | 114.9M | |
| R-Value | (0.89) | |
| Mean Square Error | 376T | |
| R-Squared | 0.79 | |
| Slope | (7,290,537) | |
| Total Sum of Squares | 27326.3T |
Cabaletta Ebit History
Other Fundumenentals of Cabaletta Bio
About Cabaletta Bio Financial Statements
Cabaletta Bio stakeholders use historical fundamental indicators, such as Cabaletta Bio's Ebit, to determine how well the company is positioned to perform in the future. Although Cabaletta Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cabaletta Bio's assets and liabilities are reflected in the revenues and expenses on Cabaletta Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cabaletta Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | -103.6 M | -98.4 M | |
| EBITDA | -99.3 M | -94.3 M | |
| Ebt Per Ebit | 1.06 | 1.21 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:Check out the analysis of Cabaletta Bio Correlation against competitors. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. Projected growth potential of Cabaletta fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cabaletta Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Cabaletta Bio's market price often diverges from its book value, the accounting figure shown on Cabaletta's balance sheet. Smart investors calculate Cabaletta Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Cabaletta Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cabaletta Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cabaletta Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.